ストックスクリーナーアプリを入手
360.23
0.07%
0.26
アフターアワーズ：
360.23
前日終値:
$359.97
開ける：
$359.46
24時間の取引高:
1.00M
Relative Volume:
0.72
時価総額：
$70.08B
収益：
$325.78B
当期純損益:
$1.64B
株価収益率:
43.33
EPS:
8.3139
ネットキャッシュフロー:
$3.61B
1週間 パフォーマンス:
-1.50%
1か月 パフォーマンス:
+1.52%
6か月 パフォーマンス:
+24.07%
1年 パフォーマンス:
+49.20%
1日の値動き範囲:
$358.16
$362.60
1週間の範囲:
$347.03
$374.89
52週間の値動き範囲:
$240.09
$377.54
Cencora Inc Stock (COR) Company Profile
Compare COR vs MCK, CAH, HSIC, ACH
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
360.23 | 70.03B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
MCK
Mckesson Corporation
|
946.97 | 115.93B | 397.96B | 4.55B | 9.64B | 34.77 |
|
CAH
Cardinal Health Inc
|
224.99 | 53.08B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
78.03 | 9.09B | 12.50B | 314.00M | 421.00M | 2.44 |
|
ACH
Accendra Health Inc
|
2.41 | 180.99M | 0 | 0 | 0 | 0.00 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-29 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | アップグレード | Jefferies | Hold → Buy |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-06-03 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 再開されました | Mizuho | Outperform |
| 2024-09-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-14 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-31 | 開始されました | Citigroup | Buy |
| 2023-01-31 | 再開されました | Evercore ISI | Outperform |
| 2022-10-11 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-07-11 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-06-07 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-05-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-04-12 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2021-03-12 | 再開されました | Evercore ISI | In-line |
| 2021-02-04 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-02-02 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-01-06 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-01-06 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 開始されました | Mizuho | Neutral |
| 2020-08-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 開始されました | Barclays | Underweight |
| 2020-06-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 再開されました | Credit Suisse | Outperform |
| 2020-04-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-03-17 | アップグレード | Citigroup | Neutral → Buy |
| 2020-02-11 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Hold |
| 2019-07-10 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 開始されました | Guggenheim | Buy |
| 2019-04-10 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-02-11 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-10 | ダウングレード | Jefferies | Buy → Hold |
| 2018-10-26 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 開始されました | Berenberg | Buy |
| 2018-07-17 | 再開されました | Stifel | Hold |
| 2018-04-09 | 開始されました | MoffettNathanson | Buy |
| 2018-03-12 | アップグレード | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 開始されました | JP Morgan | Neutral |
| 2017-09-22 | 開始されました | William Blair | Outperform |
すべてを表示
Cencora Inc (COR) 最新ニュース
Cencora Stock Rallied 50% Last Year. Here’s the Numbers Behind Sustaining That Momentum - TIKR.com
3 Firms Steer $3.5B Cencora, Covetrus Animal Health Merger - Law360
Cencora, Inc. (COR) Announces Merger of MWI Animal Health with C - GuruFocus
Cencora (COR) and Covetrus Announce $3.5 Billion Merger - GuruFocus
Cencora to refocus on drug distribution with $3.5 billion divestiture of animal health unit - marketscreener.com
Cencora to Receive $1.25B Cash, $2.25B Equity for MWI in $3.5B Deal; Retains 34.3% Stake - TradingView
Cencora's MWI Animal Health to Merge With Covetrus - marketscreener.com
Cencora's animal health unit to merge with Covetrus in $3.5 billion deal - marketscreener.com
Animal health shake-up: Covetrus and MWI plan $3.5B merger - Stock Titan
Cencora, Inc. $COR Shares Sold by HighTower Advisors LLC - MarketBeat
What are Wall Street analysts' target price for Cencora stock? - MSN
OneOncology CEO on company's future after $7.4 billion deal - The Business Journals
Is the Options Market Predicting a Spike in Cencora Stock? - TradingView
Vanguard Group Inc. Boosts Stock Position in Cencora, Inc. $COR - MarketBeat
Skandinaviska Enskilda Banken AB publ Decreases Position in Cencora, Inc. $COR - MarketBeat
JPMorgan Chase & Co. Buys 821,098 Shares of Cencora, Inc. $COR - MarketBeat
PNC Financial Services Group Inc. Cuts Holdings in Cencora, Inc. $COR - MarketBeat
Cornerstone Advisory LLC Has $3.57 Million Stake in Cencora, Inc. $COR - MarketBeat
Dividend Watch: Can Cencora Inc grow without external fundingWeekly Gains Report & Safe Capital Growth Stock Tips - baoquankhu1.vn
Cencora Closes $3.0 Billion Senior Notes Offering - marketscreener.com
Cencora, Inc. $COR Stake Raised by Tobam - MarketBeat
Cencora, Inc. $COR Shares Acquired by State of New Jersey Common Pension Fund D - MarketBeat
Shell Asset Management Co. Has $1.44 Million Stake in Cencora, Inc. $COR - MarketBeat
Assetmark Inc. Raises Stock Holdings in Cencora, Inc. $COR - MarketBeat
Aberdeen Group plc Has $48.85 Million Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. (COR) Stock Analysis: Exploring A 11.74% Upside Potential - DirectorsTalk Interviews
TimesSquare Capital Management LLC Sells 22,292 Shares of Cencora, Inc. $COR - MarketBeat
Cencora Prices $3 Billion Senior Notes Offering - The Globe and Mail
Can Cencora Inc. ride the EV waveTrade Entry Summary & Consistent Return Strategy Ideas - mfd.ru
Cencora completes $3 billion senior notes offering By Investing.com - Investing.com Australia
Cencora delivers $85.9B quarter, lifts profit outlook - MSN
Cencora completes $3 billion senior notes offering - Investing.com
Cencora, Inc. Completes the Sale of $3.0 Billion Aggregate Principal Amount of the Senior Notes - marketscreener.com
Cencora Closes $3 Billion Senior Notes Offering - marketscreener.com
Cencora raises $3B to repay 364-day credit for OneOncology acquisition - Stock Titan
Does Cencora Inc. have strong EBITDA marginsJuly 2025 Update & Entry Point Confirmation Signals - mfd.ru
Barclays Raises Price Target for Cencora (COR) to $425 | COR Sto - GuruFocus
Cencora Delivers $85.9B Quarter, Lifts Profit Outlook - MyChesCo
Longbow Finance SA Purchases Shares of 33,767 Cencora, Inc. $COR - MarketBeat
Advisors Asset Management Inc. Has $5.41 Million Position in Cencora, Inc. $COR - MarketBeat
Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know - Finviz
Cencora Puts Conshohocken Headquarters Tower Up For Sale - Hoodline
Cencora, Inc. $COR Shares Purchased by Rhumbline Advisers - MarketBeat
Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There - simplywall.st
Caprock Group LLC Makes New $3.57 Million Investment in Cencora, Inc. $COR - MarketBeat
Atria Investments Inc Decreases Stake in Cencora, Inc. $COR - MarketBeat
Cencora Issues $3 Billion in Senior Unsecured Notes - TipRanks
Cencora, Inc. Announces Pricing of Senior Notes Offering - TradingView
Ex-Dividend Reminder: Cencora, Amgen and Oppenheimer Holdings - Nasdaq
Wealthfront Advisers LLC Increases Stock Position in Cencora, Inc. $COR - MarketBeat
5 Revealing Analyst Questions From Cencora's Q4 Earnings Call - Finviz
Cencora Inc (COR) 財務データ
収益
当期純利益
現金流量
EPS
0.26%
0.05%
大文字化:
|
ボリューム (24 時間):